Literature DB >> 3244401

P2-purinoceptor induced prostaglandin synthesis in primary rat astrocyte cultures.

P J Gebicke-Haerter1, S Wurster, A Schobert, G Hertting.   

Abstract

Adenosine triphosphate (ATP) is one of the cotransmitters that are commonly released at catecholaminergic and cholinergic nerve terminals. The glial cell type most closely associated with the synapse is the astrocyte and, thus, is the next cellular element beside the postsynaptic neuron to face the transmitters released. This report gives evidence of P2-purinoceptors on cultured astroglial cells. Upon stimulation with nucleoside triphosphates and nucleoside diphosphates, the cells respond with synthesis of prostaglandins of the D2 type, which is the predominant prostaglandin made in rat brain. Nucleoside triphosphate analogues, such as 5'-adenyl-imido diphosphate, beta,gamma-methylene, or alpha,beta-methylene ATP were less effective than ATP or its non-hydrolysable analogue ATP [gamma S]. The receptor was desensitized by ATP [gamma S] within 15 min, whereas desensitization by alpha,beta-methylene ATP was significantly delayed. 8-phenyl-theophylline (10(-4) M) had no influence on ATP-stimulated prostaglandin synthesis. Adenosine 5'-monophosphate (AMP) and adenosine were unable to stimulate prostaglandin D2 formation. According to the common nomenclature for purinoceptors, the described astroglial receptor would fulfill the characteristics of a P2-purinoceptor. Furthermore, it is shown that pertussis toxin sensitive G-proteins influence some early step in prostaglandin synthesis. The inactivation of these proteins results in reduced prostaglandin formation. It is assumed that ATP serves as an important mediator in the cross-talk between neurons and astroglial cells at the synaptic cleft.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244401     DOI: 10.1007/bf00165638

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  Multiple pertussis toxin substrates as candidates for regulatory G proteins of adenylate cyclase coupled to the somatostatin receptor in primary rat astrocytes.

Authors:  P J Gebicke-Haerter; A Seregi; S Wurster; A Schobert; C Allgaier; G Hertting
Journal:  Neurochem Res       Date:  1988-10       Impact factor: 3.996

2.  Light activation of phospholipase A2 in rod outer segments of bovine retina and its modulation by GTP-binding proteins.

Authors:  C L Jelsema
Journal:  J Biol Chem       Date:  1987-01-05       Impact factor: 5.157

3.  Immunocytochemical localization of the guanine nucleotide-binding protein Go in primary cultures of neuronal and glial cells.

Authors:  P Brabet; A Dumuis; M Sebben; C Pantaloni; J Bockaert; V Homburger
Journal:  J Neurosci       Date:  1988-02       Impact factor: 6.167

4.  Radioimmunological determination of prostaglandin D2 synthesis in human thrombocytes.

Authors:  H Anhut; B A Peskar; W Wachter; B Gräbling; B M Peskar
Journal:  Experientia       Date:  1978-11-15

5.  Phorbol ester stimulation of prostanoid synthesis by cultured astrocytes.

Authors:  J Jeremy; S Murphy; C Morrow; B Pearce; P Dandona
Journal:  Brain Res       Date:  1987-09-01       Impact factor: 3.252

6.  Adenosine triphosphate stimulates inositol phospholipid metabolism and prostacyclin formation in adrenal medullary endothelial cells by means of P2-purinergic receptors.

Authors:  E J Forsberg; G Feuerstein; E Shohami; H B Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

7.  Modulatory action of prostaglandin D2 on the release of 3H-norepinephrine from rat cerebellar slices.

Authors:  M Namima; K Okamoto
Journal:  Jpn J Pharmacol       Date:  1987-02

8.  Phorbol diester TPA elicits prostaglandin E release from cultured rat astrocytes.

Authors:  H P Hartung; K V Toyka
Journal:  Brain Res       Date:  1987-08-11       Impact factor: 3.252

9.  Antagonism by clonidine of neuronal depressant responses to adenosine, adenosine-5'-monophosphate and adenosine triphosphate.

Authors:  T W Stone; D A Taylor
Journal:  Br J Pharmacol       Date:  1978-11       Impact factor: 8.739

10.  Eicosanoid synthesis and release from primary cultures of rat central nervous system astrocytes and meningeal cells.

Authors:  S Murphy; J Jeremy; B Pearce; P Dandona
Journal:  Neurosci Lett       Date:  1985-10-24       Impact factor: 3.046

View more
  7 in total

Review 1.  Purinoceptors on neuroglia.

Authors:  Alexei Verkhratsky; Alexei Verkhrasky; Oleg A Krishtal; Geoffrey Burnstock
Journal:  Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.590

2.  In vivo long-term synaptic plasticity of glial cells.

Authors:  Eve-Lyne Bélair; Joanne Vallée; Richard Robitaille
Journal:  J Physiol       Date:  2010-02-08       Impact factor: 5.182

3.  Cultured chick sympathetic neurons: modulation of electrically evoked noradrenaline release by P2-purinoceptors.

Authors:  C Allgaier; H Wellmann; A Schobert; I von Kügelgen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-07       Impact factor: 3.000

4.  Interleukin-1 enhances the ATP-evoked release of arachidonic acid from mouse astrocytes.

Authors:  N Stella; A Estellés; J Siciliano; M Tencé; S Desagher; D Piomelli; J Glowinski; J Prémont
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

5.  Inhibition by n-3 fatty acids of arachidonic acid metabolism in a primary culture of astroglial cells.

Authors:  A Petroni; M Salami; M Blasevich; N Papini; C Galli
Journal:  Neurochem Res       Date:  1994-09       Impact factor: 3.996

6.  Extracellular ATP induces stellation and increases glial fibrillary acidic protein content and DNA synthesis in primary astrocyte cultures.

Authors:  J T Neary; L Baker; S L Jorgensen; M D Norenberg
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Pyrimidine nucleotide-stimulated thromboxane A2 release from cultured glia.

Authors:  D Langley; B Pearce
Journal:  Cell Mol Neurobiol       Date:  1998-10       Impact factor: 5.046

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.